West Pharmaceutical Services, Inc. [WST] stock is trading at $313.63, down -0.37%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The WST shares have gain 3.58% over the last week, with a monthly amount glided 3.74%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
West Pharmaceutical Services, Inc. [NYSE: WST] stock has seen the most recent analyst activity on February 07, 2024, when Jefferies upgraded its rating to a Buy and also boosted its price target to $536 from $323. Previously, BofA Securities upgraded its rating to Buy on June 16, 2023, and elevated its price target to $405. On April 11, 2023, upgrade upgraded it’s rating to Overweight and revised its price target to $400 on the stock. Deutsche Bank started tracking the stock assigning a Hold rating and suggested a price target of $250 on December 14, 2022. UBS initiated its recommendation with a Neutral and recommended $250 as its price target on November 30, 2022. BofA Securities downgraded its rating to Neutral for this stock on October 28, 2022, and downed its price target to $250. In a note dated November 10, 2020, KeyBanc Capital Markets initiated an Overweight rating and provided a target price of $350 on this stock.
West Pharmaceutical Services, Inc. [WST] stock has fluctuated between $265.00 and $415.73 over the past year. Currently, Wall Street analysts expect the stock to reach $345.33 within the next 12 months. West Pharmaceutical Services, Inc. [NYSE: WST] shares were valued at $313.63 at the most recent close of the market. An investor can expect a potential return of 10.11% based on the average WST price forecast.
Analyzing the WST fundamentals
West Pharmaceutical Services, Inc. [NYSE:WST] reported sales of 2.88B for the trailing twelve months, which represents a drop of -6.92%. Gross Profit Margin for this corporation currently stands at 0.36% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.21%, and Net Profit Margin reading is 0.18%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.19 and Total Capital is 0.21. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 310.48 points at the first support level, and at 307.33 for the second support level. However, for the 1st resistance point, the stock is sitting at 318.27, and for the 2nd resistance point, it is at 322.91.
Ratios To Look Out For
For context, West Pharmaceutical Services, Inc.’s Current Ratio is 2.34. As well, the Quick Ratio is 1.68, while the Cash Ratio is 0.7. Considering the valuation of this stock, the price to sales ratio is 7.91, the price to book ratio is 8.84 and price to earnings (TTM) ratio is 44.61.
Transactions by insiders
Recent insider trading involved Witherspoon Charles, VP & Treasurer, that happened on Aug 19 ’24 when 1029.0 shares were sold. Director, Hofmann Thomas W completed a deal on May 10 ’24 to sell 617.0 shares. Meanwhile, President, CEO and Board Chair Green Eric Mark sold 30732.0 shares on Aug 06 ’24.
